WallStSmart

Salesforce.com Inc (CRM)vsNice Ltd ADR (NICE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 1321% more annual revenue ($42.83B vs $3.01B). CRM leads profitability with a 18.7% profit margin vs 17.6%. NICE appears more attractively valued with a PEG of 0.53. CRM earns a higher WallStSmart Score of 71/100 (B).

CRM

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.3Quality: 4.5
Piotroski: 5/9Altman Z: 1.50

NICE

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 7.0Value: 9.3Quality: 7.5
Piotroski: 4/9Altman Z: 3.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+74.7%)

Margin of Safety

+74.7%

Fair Value

$722.63

Current Price

$185.66

$536.97 discount

UndervaluedFair: $722.63Overvalued
NICEUndervalued (+34.4%)

Margin of Safety

+34.4%

Fair Value

$169.13

Current Price

$93.14

$75.99 discount

UndervaluedFair: $169.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM5 strengths · Avg: 8.8/10
EPS GrowthGrowth
52.2%10/10

Earnings expanding 52.2% YoY

Market CapQuality
$164.49B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

NICE4 strengths · Avg: 9.5/10
P/E RatioValuation
10.5x10/10

Attractively priced relative to earnings

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.9510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.538/10

Growing faster than its price suggests

Areas to Watch

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.223/10

Elevated debt levels

NICE2 concerns · Avg: 2.0/10
Price/BookValuation
38.0x2/10

Trading at 38.0x book value

EPS GrowthGrowth
-61.7%2/10

Earnings declined 61.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 18.7% and operating margin at 21.8%. Revenue growth of 13.3% demonstrates continued momentum.

Bull Case : NICE

The strongest argument for NICE centers on P/E Ratio, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.6% and operating margin at 16.5%. PEG of 0.53 suggests the stock is reasonably priced for its growth.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Bear Case : NICE

The primary concerns for NICE are Price/Book, EPS Growth.

Key Dynamics to Monitor

CRM carries more volatility with a beta of 1.14 — expect wider price swings.

CRM is growing revenue faster at 13.3% — sustainability is the question.

CRM generates stronger free cash flow (6.6B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (71/100 vs 64/100), backed by strong 18.7% margins and 13.3% revenue growth. NICE offers better value entry with a 34.4% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Nice Ltd ADR

TECHNOLOGY · SOFTWARE - APPLICATION · USA

NICE Ltd. provides business software solutions globally. The company is headquartered in Ra'anana, Israel.

Visit Website →

Want to dig deeper into these stocks?